warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
Seattle Children's Hospital / PBMTC GVH 1201: Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Brief Description  
To determine the impact that abatacept will make on the incidence of early, severe acute GVHD (aGvHD), when it is added to a standard GvHD prophylaxis regimen during unrelated-donor hematopoietic stem cell transplantation (HSCT) for patients with hematologic malignancies.
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Non-Hodgkin's Lymphoma
Status  
OPEN
Start Date  
03/20/2017
IRB Number  
00017275
Principal Investigator  
Eckrich, Michael James
Contact Name  
Tracy L Fukes

For More Information, Contact  Tracy  L, Fukes
Phone:  980-442-2310 Fax:    
Email:  tracy.fukes@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204
Close